Two Sigma Securities’s Sarepta Therapeutics SRPT Stock Holding History

Two Sigma Securities’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,980	Closed	-$382K	–	2045
2025 Q1	$382K	Buy	+5,980	New	+$630K	0.06%	469
2022 Q1	–	Sell	-4,532	Closed	-$408K	–	2485
2021 Q4	$408K	Buy	+4,532	New	+$387K	0.02%	635
2021 Q1	–	Sell	-1,665	Closed	-$284K	–	1664
2020 Q4	$284K	Buy	+1,665	New	+$247K	0.01%	1093
2020 Q1	–	Sell	-7,434	Closed	-$959K	–	2231
2019 Q4	$959K	Buy	+7,434	New	+$750K	0.01%	1066
2019 Q1	–	Sell	-1,979	Closed	-$216K	–	2404
2018 Q4	$216K	Buy	+1,979	New	+$248K	﹤0.01%	1653
2017 Q3	–	Sell	-10,566	Closed	-$356K	–	1198
2017 Q2	$356K	Buy	+10,566	New	+$344K	0.07%	293

Other funds holding SRPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Two Sigma Securities's SRPT Position: Q2 2025 in Review

Two Sigma Securities sold out of Sarepta Therapeutics (SRPT) in Q2 2025, closing a stake of 5,980 shares — an estimated $382K sold.

Two Sigma Securities first reported a position in SRPT in Q2 2017 and held it in 6 quarters. The position peaked at $959K in Q4 2019. 362 funds tracked by Wall St. Rank hold SRPT as of Q2 2025.

Two Sigma Securities reported no remaining Sarepta Therapeutics position as of Q2 2025 after selling out during the quarter.
Two Sigma Securities sold 5,980 Sarepta Therapeutics shares in Q2 2025, an estimated $382K.
Two Sigma Securities first reported a position in Sarepta Therapeutics in Q2 2017 and held it in 6 quarters.
Two Sigma Securities's Sarepta Therapeutics position peaked at $959K in Q4 2019.
362 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.